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Introduction
The growing availability of high-throughput sequencing
continues to increase the number of identified genetic
variants [1, 2]. For example, the size of the dbSNP database
[3] has grown exponentially over the past years to ~150
million human single nucleotide polymorphisms and short
genomic variants. Unfortunately, the characterization,
annotation, and interpretation of these variants are
still lagging. In particular, their implication in disease
is one of the major challenges in personalized medi-
cine [4–8].
The 5th edition of the Variant Interpretation Special
Interest Group (VarI-SIG, formerly SNP-SIG) meeting
[9–12] was held on July 11th, 2015 at the joint ISMB/
ECCB meeting in Dublin, Ireland. The central VarI-SIG
themes were “Annotation and prediction of structural/
functional impacts of coding variants” and “Genetic vari-
ants as effectors of change: disease and evolution”. Our
meeting is organized as a venue for the development of
a research network of scientists, necessary for facilitating
the exchange of ideas and establishing new collabora-
tions. This year’s meeting attracted over 60 participants,
with eight research talks and five presentations from the
leading scientists in the field.
Manuscript submission and review
For this year’s VarI-SIG special issue we received eight
manuscript submissions. All manuscripts were evalu-
ated by at least two reviewers, selecting from a panel of
three editors and 17 other experts in the field (see
Acknowledgements). After 2 rounds of review seven
manuscripts were accepted for publication. These
address a description of a phenotype-dependent variant/
gene prioritization method [13], annotation of variants
specifically in protein kinases [14] and, generically, in
regulatory regions [15], analysis of genetic variants asso-
ciated with Alzheimer’s Disease [16], identification of
the role of protein stability OMIM disease-related vari-
ants [17], and the study of mutation profiles in cancer
genomes [18, 19].
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We are working to organize the next VarI-SIG meeting
(ISMB 2016; Orlando, Florida; July 9th, 2016). Further
information about this coming meeting is available on
our website (http://varisig.biofold.org).
Last year, in collaboration with the ISMB organizers,
we introduced VarI-COSI (Variant Interpretation Com-
munity of Special Interest). VarI-COSI is a community
aimed at sharing relevant information, discussing ideas,
and providing training and support networks in the field
of genomic interpretation. The web portal for VarI-COSI
is under development and is accessible via ISCB Con-
nect (http://connect.iscb.org/home). We welcome input
and participation from the variation interpretation
community.
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